Condition
Chlordecone (Kepone) Toxicity
Total Trials
1
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
1 treatments under study, led by Limosilactobacillus Reuteri
Research Leaders
6 sponsors active, led by Biological Resource Centre, Martinique
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Not Yet Recruiting1
Clinical Trials (1)
Research Network
Common Treatments
- Limosilactobacillus Reuteri1
Active Sponsors
- Biological Resource Centre, Martinique1
- BioGaia AB1
- Regional Health Agency, Martinique1
- Reims University hospital1
- University Hospital, Limoges1
Top Investigators
University Hospital of Martinique